Page last updated: 2024-11-04

succinylacetone and Autosomal Recessive Chronic Granulomatous Disease

succinylacetone has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 1 studies

succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, L1
Zhen, L1
Dinauer, MC1

Other Studies

1 other study available for succinylacetone and Autosomal Recessive Chronic Granulomatous Disease

ArticleYear
Biosynthesis of the phagocyte NADPH oxidase cytochrome b558. Role of heme incorporation and heterodimer formation in maturation and stability of gp91phox and p22phox subunits.
    The Journal of biological chemistry, 1997, Oct-24, Volume: 272, Issue:43

    Topics: 3T3 Cells; Animals; Cell Differentiation; Cell Membrane; COS Cells; Cytochrome b Group; Dimerization

1997